These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Abeta-2M-amyloidosis and related bone diseases. Kazama JJ, Yamamoto S, Takahashi N, Ito Y, Maruyama H, Narita I, Gejyo F. J Bone Miner Metab; 2006 Aug; 24(2):182-4. PubMed ID: 16502130 [Abstract] [Full Text] [Related]
29. Electron-microscopic and immunohistochemical study of beta-2-microglobulin-related amyloidosis. Nishi S, Ogino S, Maruyama Y, Honma N, Gejyo F, Morita T, Arakawa M. Nephron; 1990 Aug; 56(4):357-63. PubMed ID: 1706823 [Abstract] [Full Text] [Related]
30. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis. Brancaccio D, Ghiggeri GM, Braidotti P, Garberi A, Gallieni M, Bellotti V, Zoni U, Gusmano R, Coggi G. J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295 [Abstract] [Full Text] [Related]
31. [Significance of serum levels of beta-2-microglobulin in dialysis patients]. Baldrati L, Baldrati L, Delvecchio C, Capponcini C, Docci D, Turci F, Feletti C. Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750 [Abstract] [Full Text] [Related]
32. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H. J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390 [Abstract] [Full Text] [Related]
37. Pore formation by beta-2-microglobulin: a mechanism for the pathogenesis of dialysis associated amyloidosis. Hirakura Y, Kagan BL. Amyloid; 2001 Jun; 8(2):94-100. PubMed ID: 11409039 [Abstract] [Full Text] [Related]